Overview

The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus

Status:
Unknown status
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
A 20 week study to assess the safety and efficacy of etanercept(Enbrel®)for the treatment of Discoid Lupus Erythematosus
Phase:
Phase 2
Details
Lead Sponsor:
Florida Academic Dermatology Centers
Treatments:
Etanercept